These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 2522247)
21. [Combination intra-arterial chemotherapy with degradable starch microspheres and mitomycin C against inoperable hepatic metastases]. Koike S; Fujimoto S; Endoh F; Guhji M; Ooi T; Okui K Gan To Kagaku Ryoho; 1988 Mar; 15(3):431-5. PubMed ID: 2831818 [TBL] [Abstract][Full Text] [Related]
22. [Multi-center cooperative phase II study of combined infusion of PJ-203 (degradable starch microspheres) into hepatic artery in metastatic liver cancer]. Taguchi T; Tanikawa K; Sano K; Nakamura H; Okawa T; Miura T; Ogawa N Gan To Kagaku Ryoho; 1993 Oct; 20(13):2015-25. PubMed ID: 8215476 [TBL] [Abstract][Full Text] [Related]
23. [Hepatic arterial infusion and occlusion technique for the evaluation of the hepatic resection to control the local liver tumor]. Hirakata A; Kato S; Kawano Y; Mineta S; Taniai N; Mamada Y; Yokomuro S; Yoshida H; Akimaru K; Tajiri T Gan To Kagaku Ryoho; 2004 Oct; 31(11):1749-51. PubMed ID: 15553703 [TBL] [Abstract][Full Text] [Related]
24. Intra-arterial infusion of doxorubicin with degradable starch microspheres. Improvement of hepatic tumor drug uptake. Sigurdson ER; Ridge JA; Daly JM Arch Surg; 1986 Nov; 121(11):1277-81. PubMed ID: 3778200 [TBL] [Abstract][Full Text] [Related]
25. [Liver tumor targeting of drugs: Spherex, a vascular occlusive agent]. Taguchi T Gan To Kagaku Ryoho; 1995 Jun; 22(7):969-76. PubMed ID: 7794007 [TBL] [Abstract][Full Text] [Related]
27. [Effects of intra-arterial infusion of degradable starch microspheres on liver tissue blood flow]. Shibasaki M; Sanjo K; Bandai Y; Imamura H; Nomura Y; Hirata M; Chou S; Minagawa M; Hashimoto M; Ohashi K Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1706-10. PubMed ID: 2389959 [TBL] [Abstract][Full Text] [Related]
28. Pilot study on the regional treatment of colorectal liver metastases by intermittent arterial ischaemia with degradable starch microspheres and arterial and portal infusion with mitomycin C plus 5-fluorouracil--a clinical trial led by the Gastrointestinal Tumour Cooperative Group E.O.R.T.C. Gerard A Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2627-32. PubMed ID: 3137885 [TBL] [Abstract][Full Text] [Related]
29. Theoretic and experimental aspects of regional liver infusion. August DA Surg Oncol Clin N Am; 1996 Apr; 5(2):399-409. PubMed ID: 9019360 [TBL] [Abstract][Full Text] [Related]
30. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Martin RC; Edwards MJ; McMasters KM Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489 [TBL] [Abstract][Full Text] [Related]
31. The effect of portal venous flow on the washout of a regionally injected marker substance 99mTc-methylene diphosphonate after hepatic arterial blockade with degradable starch microspheres. Nott DM; Yates J; Grime SJ; Maltby M; Cooke TG; Jenkins SA Eur J Surg Oncol; 1992 Aug; 18(4):347-52. PubMed ID: 1521628 [TBL] [Abstract][Full Text] [Related]
33. The value of postoperative hepatic arterial infusion following curative liver resection. Lorenz M; Staib-Sebler E; Koch B; Gog C; Waldeyer M; Encke A Anticancer Res; 1997; 17(5B):3825-33. PubMed ID: 9427788 [TBL] [Abstract][Full Text] [Related]
34. [Audit of the safety of hepatic arterial infusion of degradable starch microspheres (DSM). Adriamycin (ADM).mitomycin C (MMC) on aged patients with liver metastases of colorectal cancer]. Takeuchi I; Ishida H; Kuwabara K; Hashimoto D; Osada H; Kashimada A; Matumoto Y; Miura T Gan To Kagaku Ryoho; 2002 Nov; 29(12):2374-6. PubMed ID: 12484078 [TBL] [Abstract][Full Text] [Related]
35. [Clinical trial of degradable starch microspheres (DSM) in the treatment of hepatic malignancies by intra-arterial infusion of anticancer drugs--relationship between quantity of DSM and blockade of arterial blood flow]. Yamada T; Matsuoka T; Manabe T; Takashima S; Kobayashi N; Tamaoka K; Nakajima T; Nakatsuka H; Nakamura K; Minakuchi K Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Nov; 46(11):1259-66. PubMed ID: 3822782 [No Abstract] [Full Text] [Related]
36. Intra-arterial mitomycin C treatment of unresectable liver tumours. Preliminary results on the effect of degradable starch microspheres. Starkhammar H; HÃ¥kansson L; Morales O; Svedberg J Acta Oncol; 1987; 26(4):295-300. PubMed ID: 3120760 [TBL] [Abstract][Full Text] [Related]
37. Angiotensin alteration of drug uptake in an experimental model of hepatic metastases. Trezona T; Butler JA; Vargas H J Surg Res; 1991 Aug; 51(2):124-7. PubMed ID: 1830915 [TBL] [Abstract][Full Text] [Related]
38. Improved antitumor effect of the nitrosourea drugs tauromustine (TCNU) and carmustine (BCNU) on a rat liver adenocarcinoma after hepatic arterial administration with degradable starch microspheres. Roos G; el Hag IA; Teder H; Stenram U Anticancer Res; 1991; 11(1):13-6. PubMed ID: 2018346 [TBL] [Abstract][Full Text] [Related]
39. [Effect of degradable starch microspheres (DSM) on hepatic hemodynamics]. Koike S; Fujimoto S; Guhji M; Shrestha RD; Kokubun M; Kobayashi K; Kiuchi S; Konno C; Okui K Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2818-21. PubMed ID: 2506822 [TBL] [Abstract][Full Text] [Related]
40. [Biliary and arterial obstructive processes in regional chemotherapy with FUDR]. Schumacher KA; Roth J; Safi F; Friedrich JM; Weidenmaier WE Rofo; 1988 Nov; 149(5):476-9. PubMed ID: 2848277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]